{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:08:14Z","timestamp":1649077694244},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13312-015-0648-4","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T02:45:14Z","timestamp":1432608314000},"page":"421-425","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intermittent short course rifapentine-isoniazid combination for preventing tuberculosis in children"],"prefix":"10.1007","volume":"52","author":[{"given":"Joseph L.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Parakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"648_CR1","volume-title":"TB INDIA 2014. Revised National TB Control Programme","author":"Central TB Division","year":"2015","unstructured":"Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. TB INDIA 2014. Revised National TB Control Programme. Annual Status Report. Available from: http:\/\/www.tbcindia.nic.in\/pdfs\/TB%20INDIA%202014.pdf. Accessed April 14, 2015."},{"key":"648_CR2","volume-title":"National Guidelines on Diagnosis and Treatment of Pediatric Tuberculosis","author":"No authors listed.","year":"2015","unstructured":"No authors listed. National Guidelines on Diagnosis and Treatment of Pediatric Tuberculosis. Available from: http:\/\/tbcindia.nic.in\/Paediatric%20guidelines_New.pdf. Accessed April 14, 2015."},{"key":"648_CR3","first-page":"301","volume":"50","author":"A Kumar","year":"2013","unstructured":"Kumar A, Gupta D, Nagaraja SB, Singh V, Sethi GR, Prasad J. Indian Academy of Pediatrics. Updated national guidelines for pediatric tuberculosis in India, 2012. Indian Pediatr. 2013;50:301\u20136.","journal-title":"Updated national guidelines for pediatric tuberculosis in India, 2012. Indian Pediatr."},{"key":"648_CR4","unstructured":"Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR. 2000;49:RR-6. Available from: http:\/\/www.cdc.gov\/mmwr\/PDF\/rr\/rr4906.pdf. Accessed April 14, 2015."},{"key":"648_CR5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"key":"648_CR6","first-page":"1650","volume":"60","author":"Centers for Disease ControlPrevention CDC.","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR. 2011;60:1650\u20133.","journal-title":"MMWR."},{"key":"648_CR7","volume-title":"World Health Organization 2015","author":"World Health Organization.","year":"2015","unstructured":"World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. World Health Organization 2015. Available from: http:\/\/www.who.int\/tb\/publications\/ltbi_document_page\/en\/ Accessed April 14, 2015."},{"key":"648_CR8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/508278","volume":"43","author":"SS Munsiff","year":"2006","unstructured":"Munsiff SS, Kambili C, Ahuja SD. Rifapentine for the treatment of pulmonary tuberculosis. Clin Infect Dis. 2006;43:1468\u201375.","journal-title":"Clin Infect Dis."},{"key":"648_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jac\/46.4.571","volume":"46","author":"P Pascale Bemer-Melchiora","year":"2000","unstructured":"Pascale Bemer-Melchiora P, Bryskierb, A, Drugeona HB. Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex. Antimicrob Chemother. 2000;46:571\u20136.","journal-title":"Antimicrob Chemother."},{"key":"648_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.inf.0000214963.55217.9c","volume":"25","author":"MJ Blake","year":"2006","unstructured":"Blake MJ, Abdel-Rahman SM, Jacobs RF, Lowery NK, Sterling TR, Kearns GL. Pharmacokinetics of rifapentine in children. Pediatr Infect Dis J. 2006;25:405\u20136.","journal-title":"Pediatr Infect Dis J."},{"key":"648_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","volume":"169","author":"ME Villarino","year":"2015","unstructured":"Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, et al. Treatment for preventing tuberculosis in children and adolescents: A randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169:247\u201355.","journal-title":"JAMA Pediatr."},{"key":"648_CR12","doi-asserted-by":"crossref","unstructured":"Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIVnegative people at risk of active TB. Cochrane Database Syst Rev. 2013;7:CD007545.","DOI":"10.1002\/14651858.CD007545.pub2"},{"key":"648_CR13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","volume":"161","author":"HR Stagg","year":"2014","unstructured":"Stagg HR, Zenner D, Harris RJ, Mu\u00f1oz L, Lipman MC, Abubakar I. Treatment of latent tuberculosis infection: a network meta-analysis. Ann Intern Med. 2014;161: 419\u201328.","journal-title":"Ann Intern Med"},{"key":"648_CR14","first-page":"810","volume":"13","author":"XF Gao","year":"2009","unstructured":"Gao XF, Li J, Yang ZW, Li YP. Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2009;13:810\u20139.","journal-title":"Int J Tuberc Lung Dis."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-015-0648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-015-0648-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-015-0648-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T14:38:53Z","timestamp":1566743933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-015-0648-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s13312-015-0648-4","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}